Previous 10 | Next 10 |
home / stock / cvs / cvs articles
2024 will mark a pivotal moment for the healthcare industry, particularly in drug pricing negotiations. The forthcoming year will provide the first...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
As Christmas Eve approaches, individuals are gearing up for last-minute shopping. While business closings on Christmas Eve are less comm...
The U.S. Supreme Court is set to deliberate on the future of mifepristone, a crucial drug employed in over half of all abortions within the U.S.&nb...
A congressional review of some major pharmacy chains' privacy practices found that none require a warrant before sharing customers' records...
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have hig...
An annual survey reveals the fastest growing brands in the U.S. and includes rankings for fast growth brands amongst different age groups. Likely t...
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners said he is staying with U.S. 1 Year Treasur...
CVS Health Corp (NYSE: CVS) announced a new approach called CVS 'CostVantage' that evolves the traditional pharmacy reimbursement mode...
News, Short Squeeze, Breakout and More Instantly...
2024-06-30 06:35:00 ET CVS Health (NYSE: CVS) is a top pharmacy retailer in the U.S., and over the years, it has been expanding its operations to go deeper into healthcare. The stock also provides investors with a dividend that yields 4.3%, which is more than double the S&P 50...
2024-06-27 21:02:00 ET CVS Health (NYSE: CVS) stock price is imploding as concerns about the pharmacy business continue. It has already plunged by more than 43% from its 2022 highs and is hovering at its lowest point since November 2020. Pharmacy woes are continuing The pharmacy...
2024-06-20 08:00:10 ET Andrew Mok from Barclays issued a price target of $65.00 for CVS on 2024-06-20 07:01:00. The adjusted price target was set to $65.00. At the time of the announcement, CVS was trading at $61.01. The overall price target consensus is at $109.15 with ...